The immunopathological role of vitamin D in patients with SLE: Data from a single centre registry in Hungary

Scandinavian Journal of Rheumatology

Volumn 40, Issue 2, 2011, Pages 122-126

  Szodoray, P ^a   Tarr, T ^b   Bazso, A ^c   Poor, G ^c   Szegedi, G ^b   Kiss, E ^c  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; AUTOANTIBODY; AZATHIOPRINE; CHLOROQUINE; COMPLEMENT COMPONENT C4; CORTICOSTEROID; IMMUNOGLOBULIN G; PREDNISOLONE;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PERICARDITIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SEROLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN D DEFICIENCY;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; COMPLEMENT C4; DIETARY SUPPLEMENTS; DISEASE PROGRESSION; DNA; FEMALE; HUMANS; HUNGARY; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; REGISTRIES; SEVERITY OF ILLNESS INDEX; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 79952396993     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2010.507220     Document Type: Article

References (42)

1. Cantorna MT. Vitamin D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med 2000;223:230-3. (Pubitemid 30337776)
2. Cantorna M, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med 2004;229:1136-42. (Pubitemid 39602256)
3. Griffin MD, Dong X, Kumar R. Vitamin D receptor mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation. Arch Biochem Biophys 2007;460:218-26. (Pubitemid 46589403)
4. 3) and its metabolites. Clin Nephrol 1981;16:119-25. (Pubitemid 11059961)
5. 3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 1998;101:252-62. (Pubitemid 28058925)
6. 3 inhibits antigen-induced T cell activation. J Immunol 1984;133:1748-54. (Pubitemid 14035260)
7. 3 receptors in human leukocytes. Science 1983;221:1181-3.
8. Szodoray P, Nakken B, Gaal J, Jonsson R, Szegedi A, Zold E, et al. The complex role of vitamin D in autoimmune diseases. Scand J Immunol 2008;68:261-9.
9. 3 analog with reduced hypercalcemic activity. J Invest Dermatol 2002;119:1434-42. (Pubitemid 36005632)
10. Verstuyf A, Segaert S, Verlinden L, Bouillon R, Mathieu C. Recent developments in the use of vitamin D analogues. Expert Opin Investig Drugs 2000;9:443-55. (Pubitemid 30119684)
11. 3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 1992;4:506-12.
12. 3 in human macrophages from CAPD patients. Kidney Int 2001;59:69-75. (Pubitemid 32055215)
13. Timms PM, Mannan N, Hitman GA, Noonan K, Mills PG, Syndercombe-Court D, et al. Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? Q J Med 2002;95:787-96. (Pubitemid 36032948)
14. 3 analogs as potential therapies in transplantation. Curr Opin Invest Drugs 2002;3:1458-63.
15. Bamford CR, Sibley WA, Thies C. Seasonal variation of multiple sclerosis exacerbation in Arizona. Neurology 1983;33:697-701. (Pubitemid 13102890)
16. Embry AF, Snowdon LR, Vieth R. Vitamin D, and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000;48:271-2. (Pubitemid 30617053)
17. Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60-5. (Pubitemid 38082871)
18. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Woman's Health Study. Arthritis Rheum 2004;50:72-7. (Pubitemid 38084289)
19. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-3. (Pubitemid 33055701)
20. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003;134:128-32. (Pubitemid 36050838)
21. 3 in rheumatoid arthritis patients. Clin Exp Rheumatol 1999;17:453-6. (Pubitemid 29343630)
22. Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther 2008;10:R123.
23. Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y. Anti-vitamin D, vitamin D in SLE: preliminary results. Ann N Y Acad Sci 2007;1109:550-7. (Pubitemid 47511398)
24. Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725-43.
25. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135:317-22. (Pubitemid 40194499)
26. Hollis BW, Wagner CL. Normal serum vitamin D levels. N Engl J Med 2005;352:515-6.
27. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
28. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992;3:630-40.
29. Hua X, Su J, Svenungsson E, Hurt-Camejo E, Jensen-Urstad K, Angelin B, et al. Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease. Scand J Rheumatol 2009;38:184-9.
30. Mok CC, Poon WL, Lai JP, Wong CK, Chiu SM, Wong CK, et al. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus. Scand J Rheumatol 2010;39:42-9.
31. Ben Mansour R, Lassoued S, Elgaied A, Haddouk S, Marzouk S, Bahloul Z, et al. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies. Scand J Rheumatol 2010;39:247-53.
32. Li LH, Yuan H, Pan HF, Li WX, Li XP, Ye DQ. Role of the Fcgamma receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a metaanalysis. Scand J Rheumatol 2010;39:148-54.
33. Szodoray P, Horvath IF, Papp G, Barath S, Gyimesi E, Csathy L, et al. The immunoregulatory role of vitamins A, D and E in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2010;49:211-17.
34. Bang B, Asmussen K, Sørensen OH, Oxholm P. Reduced 25-hydroxyvitamin D levels in primary Sjögren's syndrome. Correlations to disease manifestations. Scand J Rheumatol 1999;28:180-3. (Pubitemid 29298014)
35. Tjellesen L, Christiansen C. Vitamin D metabolites in normal subjects during one year. A longitudinal study. Scand J Clin Lab Invest 1983;43:85-9. (Pubitemid 13174543)
36. Vanderschueren D, Gevers G, Dequeker J, Geusens P, Nijs J, Devos P, et al. Seasonal variation in bone metabolism in young healthy subjects. Calcif Tissue Int 1991;49:84-9.
37. Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R. High disease activity at baseline does not prevent a remission in patients with systemic lupus erythematosus. Rheumatology (Oxford) 1999;38:724-7. (Pubitemid 29507388)
38. Di Munno O, Mazzantini M, Delle Sedie A, Mosca M, Bombardieri S. Risk factors for osteoporosis in female patients with systemic lupus erythematosus. Lupus 2004;13:724-30. (Pubitemid 39279792)
39. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006;5:114-17. (Pubitemid 43129539)
40. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology 2008;47:920-3. (Pubitemid 351796385)
41. Pappa HM, Bern E, Kamin D, Grand RJ. Vitamin D status in gastrointestinal and liver disease. Curr Opin Gastroenterol 2008;24:176-83. (Pubitemid 351322784)
42. Alele JD, Kamen DL. The importance of inflammation and vitamin D status in SLE-associated osteoporosis. Autoimmun Rev 2010;9:137-9.